The crucial drugs can have unintended consequences. Innovative therapies could shield the microbiome from their effects.

Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, ...

All three were hooked up to machines that provided a readout of their vital signs, and all three were prepared to have a ...

Grail (GRAL) and Quest Diagnostics (DGX) announced the initial phase of a program to improve provider access to GRAIL’s Galleri multi-cancer ...

Grail (GRAL) is rallying 15% and set a new all-time high after Quest Diagnostics (DGX) and GRAL announced earlier today that ...

Within brain health, the robust demand for AD-detect blood tests for assessing Alzheimer's disease risk drives solid growth ...

Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

Jack Meehan; Analyst; Nephron Research Erin Wright; Analyst; Morgan Stanley ...

To find out, I took Quest's Cortisol Blood Stress Hormone Test, which was offered to me for free. After my blood test, I had many residual questions about cortisol. To learn more and get my facts ...

The discovery has shed light on a complex blood interaction that has likely always been present in humans but was unnoticed ...